Maprotiline

GPTKB entity

Statements (41)
Predicate Object
gptkbp:instanceOf antidepressant
gptkbp:approvedBy 1974
gptkbp:ATCCode N06AA21
gptkbp:CASNumber 10362-21-1
gptkbp:category norepinephrine reuptake inhibitor
secondary amine
anthracenes
gptkbp:chemical_compound C20H23N
gptkbp:contraindication history of seizures
recent myocardial infarction
gptkbp:developedBy gptkb:Ciba-Geigy
gptkbp:eliminationHalfLife 43-60 hours
gptkbp:excretion renal
gptkbp:form gptkb:tablet
https://www.w3.org/2000/01/rdf-schema#label Maprotiline
gptkbp:IUPACName 3-(9,10-dihydro-9,10-ethanoanthracen-9-yl)-N-methylpropan-1-amine
gptkbp:KEGGID D08206
gptkbp:legalStatus prescription only
gptkbp:mechanismOfAction norepinephrine reuptake inhibitor
gptkbp:meltingPoint 186-188°C
gptkbp:metabolism hepatic
gptkbp:molecularWeight 277.41 g/mol
gptkbp:pregnancyCategory C
gptkbp:proteinBinding 88%
gptkbp:PubChem_CID 4026
3888
CHEMBL1407
DB00574
gptkbp:routeOfAdministration oral
gptkbp:sideEffect gptkb:orthostatic_hypotension
constipation
weight gain
seizures
drowsiness
dry mouth
gptkbp:synonym gptkb:Ludiomil
gptkbp:UNII L0IYT1Z353
gptkbp:usedFor gptkb:major_depressive_disorder
anxiety associated with depression
gptkbp:bfsParent gptkb:Antidepressants
gptkbp:bfsLayer 6